SCHEMBL13305023

SCHEMBL13305023

Cc1cnn2c(NCc3ccc(-c4nn[nH]n4)cc3)cc(C3CCCCC3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.49
▸ CHEK1 O14757 6/20 0.47
▸ CDK2 P24941 4/20 0.47
▸ CCNA2 P20248 1/20 0.47
▸ CCNA1 P78396 1/20 0.47
▸ MTOR P42345 1/20 0.40
▸ USP1 O94782 1/20 0.39
▸ WDR48 Q8TAF3 1/20 0.39
▸ CDK1 P06493 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ CDK5 Q00535 2/20 0.38
▸ FABP4 P15090 1/20 0.38
▸ FABP5 Q01469 1/20 0.38
▸ ADH5 P11766 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CCNE1 P24864 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12954308 0.89 GSK3B (0.63) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305591 0.79 GSK3B (0.52) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305605 0.79 GSK3B (0.55) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL12953751 0.73 GSK3B (0.62) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL12954197 0.71 GSK3B (0.63) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL14412975 0.71 GSK3B (0.62) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13304607 0.70 GSK3B (0.79) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL13305295 0.70 GSK3B (0.81) GSK3BCHEK1CDK2CCNA2CCNA1
SCHEMBL14050830 0.70 GSK3B (0.68) GSK3BCHEK1CDK2CCNE1
SCHEMBL13305373 0.69 CDK2 (0.45) GSK3BCDK2CDK1CDK9CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback